The development of a Wrist-Worn Reader is the latest advancement to the ID-Cap™ System, offering a promising solution to address the complex issue of medication non-adherence. Medication nonadherence is a widespread problem, resulting in...
Read more
etectRx announces record-breaking use of the ID-Cap™ System, utilized in University of Colorado’s HIV treatment study. The Quantification of Tenofovir Alafenamide Adherence and Exposure in Adults living with HIV (QUANTI-TAF) study...
Read moreThe partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor Liege, Belgium (APRIL 28th, 2022) – Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in...
Read moreetectRx CEO Valerie Sullivan recently joined Impetus Digital’s Natalie Yeadon in a Fireside Chat to talk about the use of digital pills in healthcare and clinical research. Check out the episode below (or listen to the podcast version) to learn...
Read moreetectRx CEO Valerie Sullivan recently spoke with Laurie McGraw, host of the Inspiring Women podcast about the importance of asking for things, practicing, and knowing the power and value that you bring to the table. Check out the full episode...
Read moreCancer is often highly treatable due to new therapies, especially oral agents, that have improved outcomes and survival rates, and allow patients to be treated outside the hospital setting. Yet many patients fail to take their medication...
Read moreInspiration struck the etectRx team after watching the Apple Watch Series 6 – “It Already Does That” campaign. etectRx enthusiastically created its version of “It Already Does That” highlighting our FDA cleared ID-Cap™ System. We are...
Read more“The overall experience of our study participants so far with the ID-Cap System has been very positive. They have been able to navigate it quite easily and be engaged with the system.” – Dr. Jose Castillo-Mancilla, MD, Physician and Clinical...
Read moreA study conducted between August 2017 and April 2019 with 288 participants for hepatitis C virus (HCV) treatment evaluated the impact of a digital medicine program (DMP) on medication adherence (Proteus Digital Health) in a population at risk for...
Read moreJoe Selvaggi, host of The HubWonk podcast, interviewed our CEO Valerie Sullivan about the significance of digital pill technology and how it can enhance the pharma ecosystem. Listen for more information on how our FDA-cleared ID-Cap™...
Read moreOur CEO Valerie Sullivan speaks in PharmaVOICE about failing clinical trials and our easy solution: the etectRx digital pill ID-Cap™ System. With our technology, there is no reason for clinical trial failure, and with growing remote...
Read morePharmaceutical industry blogger Gary Monk talks with Valerie Sullivan, president and CEO of etectRx about how etectRx’s ID-Cap™ System can benefit pharmaceutical companies looking to increase effectiveness of clinical trials. Watch...
Read more